Compounds > metipranolol
Page last updated: 2024-08-23

metipranolol and Conjunctival Diseases

metipranolol has been researched along with Conjunctival Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krieglstein, GK; Lemke, JH; Mietz, H; Schlötzer-Schrehardt, U1
de Keizer, RJ; de Wolff-Rouendaal, D; Derous, D; Soudijn, W1

Other Studies

2 other study(ies) available for metipranolol and Conjunctival Diseases

ArticleYear
Early conjunctival changes following treatment with metipranolol and preservatives are not reversible with dexamethasone.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 1997, Volume: 235, Issue:7

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Conjunctiva; Conjunctival Diseases; Dexamethasone; Disease Models, Animal; Extracellular Matrix; Female; Glucocorticoids; Immunohistochemistry; Metipranolol; Ophthalmic Solutions; Preservatives, Pharmaceutical; Rabbits

1997
Conjunctival keratinisation, an abnormal reaction to an ocular beta-blocker.
    Acta ophthalmologica, 1989, Volume: 67, Issue:3

    Topics: Chemical Phenomena; Chemistry; Conjunctival Diseases; Epinephrine; Female; Humans; Keratins; Metipranolol; Middle Aged; Propanolamines

1989